Influence Graph

Biopharma Shakti's Strategic Expansion Amidst India's Biotech Push

Ethereum ETFs are facing sustained outflows for three consecutive days, totaling $690 million, indicating a potential weakening of demand in the crypto investment market. This trend is occurring simultaneously with a significant increase in coordinated activity among prominent crypto entities such as Ethereum Trust, Grayscale Ethereum Classic, Fidelity Fund, and Bitcoin ETFs. The confluence of these outflows and increased coordination suggests a market-wide re-evaluation of strategies and a potential shift in investor sentiment within the cryptocurrency sector.

dormant

auto detected

Confidence: 85%

Created: Oct 02, 2026 04:47

Matured: Oct 02, 2026 05:23

Last activity: Oct 04, 2026 00:37

Sentinel

tier: low

Participants (12)

Blackrock Holdco 8 ev York Mellon Corp 7 ev Nasdaq 7 ev Ethereum Trust 7 ev Geode Capital Management 7 ev Shri Jagat Prakash Nadda 5 ev Droupadi Murmu 4 ev Unesco International Day Of Education 4 ev Nayab Singh Saini 4 ev Swachhta Abhiyan 4 ev Bhagavad Gita 4 ev Bhavna Sharma 4 ev

Recent events (5)

Ethereum ETFs Saw Outflows Three Days Running After a $690 Million Week. Is Fund Demand Drying Up? - AOL

Oct 04, 2026 TAX_DISEASE_CONVENTIONAL Tone: 1.1 Source

Bitcoin Etfs Grayscale Ethereum Classic Fidelity Fund Alexandre Prevot Shutterstock Ethereum Trust Fund Outflows
IRS flags crypto ETF tax strategies, but it is not a ban

Oct 02, 2026 TAX_FNCACT_REGULATORS Tone: -0.2 Source

Bitcoin Trust Ethereum Trust Scott Bessent U.S. Department of the Treasury Blackrock Holdco
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Average Target Price of $36.25 According to Brokerages

Oct 02, 2026 TAX_FNCACT_ANALYST Tone: 1.2 Source

Cantor Fitzgerald Nasdaq Nuvectis Pharma York Mellon Corp Blackrock Holdco Geode Capital Management +1 more
HC Wainwright Forecasts Lower Earnings for Benitec Biopharma

Oct 02, 2026 TAX_FNCACT_ANALYST Tone: 1.7 Source

Citigroup Nasdaq Geode Capital Management York Mellon Corp British Investment Company Team America +3 more
Big News Network.com "Patient-centric innovation must be central mission of life sciences industry": JP Nadda at BLSA awards "Patient-centric innovation must be central mission of life sciences industry": JP Nadda at BLSA awards "Patient-centric innovation must be central mission of life sciences industry": JP Nadda at BLSA awards

Oct 02, 2026 WB_621_HEALTH_NUTRITION_AND_POPULATION Tone: 6.3 Source

Biopharma Shakti Biotechnology Industry Research Assistance Council Department For Promotion Of Industry Eli Lilly Jivaka Arogya Navpravartan Gaurav Lv Prasad Eye Institute +26 more

Event Timeline

Subject

Object

Co-mention